Data suggest efficacy over standard of care for the treatment of psoriatic arthritis
Izokibep was well-tolerated, having a safety profile consistent with previous studies and the IL-17A inhibitor therapeutic class
Supports hypothesis that izokibep offers greater efficacy with high potency and small size, as well as strategy of evaluating IL-17A inhibition's potential for transformative efficacy across many disease states
LOS ANGELES and SOLNA, Sweden, and SHANGHAI, June 3, 2022 /PRNewswire/ -- ACELYRIN, INC., Affibody AB and Inmagene Biopharmaceuticals today announced data from a 16-week, global, Phase 2 clinical trial of izokibep in 135 patients with psoriatic arthritis (PsA) presented by Frank Behrens, MD, Associate Professor of Medicine, Head of Rheumatology Clinical Research, University Hospital & Deputy Director Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Goethe-University Frankfurt, Germany and a founding member of the Group of Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), during a podium session at the 2022 European Alliance of Associations for Rheumatology (EULAR) Congress in Copenhagen.
The randomized double-blind, placebo-controlled, Phase 2 clinical trial evaluated the safety and efficacy of izokibep dosed 80 mg every two weeks (Q2W) or 40 mg Q2W, versus placebo Q2W, in adult patients with active PsA. The global study assessed various endpoints at 16 weeks including the American College of Rheumatology (ACR) response, the Leeds Enthesitis Index (LEI), the Psoriasis Area and Severity Index (PASI) score and Quality of Life via the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire.
Endpoint
Placebo
Izokibep 80 mg Q2W
Izokibep 40 mg Q2W
ACR50
p-value
13%
52%
0.0006
48%
0.0014
Leeds Enthesitis1
(% LEI=0)
p-value for means
10%
88%
0.0003
63%
0.0095
PASI752
p-value
14%
85%
<0.0001
83%
<0.0001
PsAID
(% beyond MCID)
p-value
12%
41%
0.0017
31%
0.0418
1FAS, observed data for LEI > 0 at baseline N=43 (32%) post-hoc analysis2FAS, observed data for psoriasis BSA 3% at baseline N=74 (55%) post-hoc analysis
Story continues
"Psoriatic arthritis is a painful and debilitating inflammatory disease of the peripheral joints, skin, and nails, and it can also affect the spine," said Professor Behrens. "Furthermore, residual entheseal pain and inflammation,which occurs in up to 60% of patients, is associated with more severe disease, poorer quality of life and is considered one of the most significant unmet needs of psoriatic arthritis patients. The data presented at EULAR demonstrate there is potential opportunity for increased therapeutic efficacy in joints, entheseal pain and inflammation resolution and improved quality of life, all of which would be meaningful for patients living with psoriatic arthritis."
Izokibep was well-tolerated in the study, having a favorable safety profile consistent with that previously observed for izokibep and the IL-17A inhibitor therapeutic class. The most commonly reported AEs were injection site reaction and injection site erythema, the majority of which was mild.
"The improvements demonstrated in arthritis, psoriasis and enthesitis are exciting relative to responses reported for the current standard of care," observed Professor Peter Taylor, Norman Collison chair of musculoskeletal sciences at the University of Oxford. "Combined with theclinically meaningful improvement in disease-specific quality of life and well-tolerated safety profile, izokibep seemspromising for patients living with the painful and debilitating symptoms of psoriatic arthritis, and I am eager to see its continued development for patients."
ACELYRIN holds worldwide rights to izokibep except development and commercialization rights by Inmagene in selected Asian countries, including China, Hong Kong, South Korea, and Taiwan, and excluding Japan. Affibody holds commercialization rights in the Nordic countries.
About izokibep
To date, more than 300 patients many for up to three years have received izokibep, a unique, antibody mimetic, interleukin-17A (IL-17A) inhibitor designed to overcome the limitations of monoclonal antibodies. With high potency and small molecular size, izokibep can reach high drug exposure levels through a single, subcutaneous injection that monoclonal antibodies require IV administration to achieve. Additionally, the small size of izokibep about one tenth the size of a monoclonal antibody enables its potential to reach targeted tissues that may otherwise be inaccessible to the much larger monoclonal antibodies.
About Psoriatic Arthritis
Psoriatic arthritis (PsA) is a chronic, immune-mediated inflammatory musculoskeletal condition affecting the peripheral joints, the skin (with psoriasis), the nails, and in approximately 30 percent of individuals, the spine. Left under-treated, PsA leads to chronic joint pain, swelling, and damage with a high potential for permanent disability. Psoriatic arthritis pathology is dominated by pro-inflammatory T-helper (Th-17) cells that lead to over expression of IL-17, IL-23, and TNF cytokines.
About ACELYRIN
ACELYRIN, INC. is a Los Angeles area-based biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates and leveraging its expertise to rapidly advance these medicines to patients. For more information, please visit http://www.acelyrin.com
About Affibody AB
Affibody AB is a clinical-stage biopharmaceutical company with a broad product pipeline focused on developing innovative bi- and multi-specific next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody molecules and Albumod. Affibody is a holding of Patricia Industries. For more information, please visit http://www.affibody.com
About Inmagene Biopharmaceuticals
Inmagene Biopharmaceuticals, with wholly owned subsidiaries in San Diego, Shanghai, Hangzhou, and Wuhan, is a leading biotech company focused on immunology-related therapeutic areas. Believing in "borderless innovation", the Inmagene team integrates efficient resources worldwide to develop drugs for patients globally. Inmagene is operating twelve "Smart Innovation" programs to create and develop novel drug candidates for the global market. For more information, please visit http://www.inmagenebio.com
Disclaimer
This press release contains forward-looking statements. While ACELYRIN, INC., Affibody AB, and Inmagene Biopharmaceuticals consider the projections to be based on reasonable assumptions, these forward-looking statements may be called into question by numerous hazards and uncertainties, so that actual results may differ materially from those anticipated in such forward-looking statements.
Cision
SOURCE ACELYRIN, INC.
- What is Psoriasis? (Part 1 of 3) | HealthiNation - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Psoriasis Treatment - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Psoriasis (Understanding Disease: Dermatology) - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- I'm Just Like You - Kids and Psoriasis - 2011 Trailer - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Psoriasis And Me - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Psoriasis?..... - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Natural Treatment For Psoriasis - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- psoriasis / eczema diet help skin care advice [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- plaque psoriasis picture m3b - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Restless Legs, Arthritis, and Psoriasis Gone Going Gluten Free - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Vitamin D can Cure Psoriasis - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Reversing Psoriasis With Green Smoothies - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Effectively Treat Psoriasis [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Scalp Treatment for Psoriasis - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Scalp Psoriasis - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- How To Treat Psoriasis - Video [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Research and Markets: Global Psoriasis Drug Pipeline Capsule - 2012 Update [Last Updated On: September 18th, 2012] [Originally Added On: September 18th, 2012]
- Press Release [Last Updated On: September 19th, 2012] [Originally Added On: September 19th, 2012]
- $1.8 million grant supports investigation of psoriasis link to cardiovascular disease [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- $1.8M Grant Supports Investigation of Psoriasis Link to CVD [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- Kiwi Company Provides Scalp Relief For Coeliac Community [Last Updated On: September 20th, 2012] [Originally Added On: September 20th, 2012]
- Community News: Sept. 28 paper [Last Updated On: September 27th, 2012] [Originally Added On: September 27th, 2012]
- Novartis Psoriasis Drug Shows Promising Results [Last Updated On: September 28th, 2012] [Originally Added On: September 28th, 2012]
- Novartis data show AIN457 significantly reduced signs and symptoms in patients with hard-to-treat moderate-to-severe ... [Last Updated On: September 28th, 2012] [Originally Added On: September 28th, 2012]
- International Study Highlights Need to Support Patients With Psoriasis Suffering Feelings of Isolation, Stigmatisation ... [Last Updated On: September 30th, 2012] [Originally Added On: September 30th, 2012]
- Research and Markets: Psoriasis (Event Driven) [Last Updated On: September 30th, 2012] [Originally Added On: September 30th, 2012]
- Stiefel receives US FDA approval of Sorilux™ Foam, 0.005% for topical treatment of plaque psoriasis of the scalp [Last Updated On: September 30th, 2012] [Originally Added On: September 30th, 2012]
- Many options for psoriasis treatments [Last Updated On: October 1st, 2012] [Originally Added On: October 1st, 2012]
- Study: Psoriasis patients more prone to diabetes [Last Updated On: October 2nd, 2012] [Originally Added On: October 2nd, 2012]
- Novartis Progresses with AIN457 [Last Updated On: October 2nd, 2012] [Originally Added On: October 2nd, 2012]
- Gum disease linked to psoriasis: study [Last Updated On: October 5th, 2012] [Originally Added On: October 5th, 2012]
- Gum disease linked to psoriasis: Taiwanese study [Last Updated On: October 5th, 2012] [Originally Added On: October 5th, 2012]
- Study: People with gum disease 54% more likely to develop psoriasis [Last Updated On: October 5th, 2012] [Originally Added On: October 5th, 2012]
- Large menu of treatments for psoriasis [Last Updated On: October 6th, 2012] [Originally Added On: October 6th, 2012]
- Psoriasis Free For Life Guide for Natural Psoriasis Treatment Now Available [Last Updated On: October 7th, 2012] [Originally Added On: October 7th, 2012]
- Interim Analysis Supports Continuation of Can-Fite's Phase 2/3 Psoriasis Clinical Study with CF101 [Last Updated On: October 10th, 2012] [Originally Added On: October 10th, 2012]
- Research and Markets: Key Findings from Treatment Algorithms: Psoriasis [Last Updated On: October 10th, 2012] [Originally Added On: October 10th, 2012]
- Research and Markets: Psoriasis - Thought Leader Panel 2012 - A Summary of Persepectives from 6 Key Opinion Leaders [Last Updated On: October 11th, 2012] [Originally Added On: October 11th, 2012]
- People with severe psoriasis nearly twice at risk for diabetes [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- Idera Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2 Trial of IMO-3100 in Patients with Psoriasis [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- Psoriasis nearly doubles diabetes risk [Last Updated On: October 16th, 2012] [Originally Added On: October 16th, 2012]
- Rise in number of Pakistanis suffering from psoriasis [Last Updated On: October 16th, 2012] [Originally Added On: October 16th, 2012]
- Psoriasis Remedies Book Teaches How to Get Rid of Psoriasis [Last Updated On: October 17th, 2012] [Originally Added On: October 17th, 2012]
- Psoriasis Patients Twice As Likely To Develop Diabetes [Last Updated On: October 17th, 2012] [Originally Added On: October 17th, 2012]
- Idera Pharma: Itching For Touch Up... [Last Updated On: October 17th, 2012] [Originally Added On: October 17th, 2012]
- Psoriasis Mandate Results Released to Mark World Psoriasis Day [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Psoriasis Care Failing Patients [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- UK Survey Calls for Further Education to Help Eliminate Common Misconceptions About Psoriasis [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- International Federation of Psoriasis Associations: Put Psoriasis on the Agenda Now! [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Analysis links psoriasis, diabetes [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Psoriasis isn't skin deep [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Lake Consumer Products Announces Innovative New MG217® Psoriasis Treatment Cream that's Unlike Anything Else on the ... [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Psoriasis and Heart Disease: It's More Than Skin Deep - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- I'm back - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Purifying Lotion - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Dr stephen ferguson ND PhD psoriasis cured - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- NATURES ANTIBIOTIC - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- DIY Face Scrub Natural [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Psoriasis Free For Life E-book... - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Buy: Psoriasis Free For Life Ebook - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Ahava Liquid Salt review by Paola Bassanese Energya Ltd - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Psoriasis Free For Life Ebook - Download - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Psoriasis Free For Life Ebook - Web Link - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Vampire Transformation! - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Evans Dermatology Evans GA - Video [Last Updated On: October 31st, 2012] [Originally Added On: October 31st, 2012]
- Psoriasis Treatment Discovery Could Cure Psoriasis New Book Claims [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- My life with Psoriasis - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Johns Creek Dermatology and Family Medicine Practice Profile - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Radio Psoriasis 2 - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Joel Schlessinger MD Visits the Avene Hydrotherapy Center - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Radio Psoriasis - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Skin Salvation and Psoriasis - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Can Psoriasis Treatment Cause Hair Lost? - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Healed from Multiple Sclerosis and psoriasis! RELOAD from thedurianKing - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Psoriasis Natural Treatment - Psoriasis Cure - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- psoriasis getting cure in acupuncture-indian accu touch - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Psoriasis Interview 18010154 - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Psoriasis does not spread by touch - Skin experts - Tv9 - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Psoriasis presentation - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]
- Home Remedies for Scalp Psoriasis - Cure Psoriasis without Medication - Video [Last Updated On: November 2nd, 2012] [Originally Added On: November 2nd, 2012]